The decision is a blow to GSK, which has been racing to secure market share in a field that now includes two competitors, Pfizer and Moderna. To that end, GSK used a priority review voucher to speed its age extension application through the FDA approval process. The agency is currently rev...
was to be forced to upgrade rooms was was dumb because even though we upgraded it was still the same room. Only difference being now we had access to some lounge and drink vouchers. Why couldn't I have just had that same room without the ...